Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. The purpose of all types of NCI-Designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious research into a single transdisciplinary research enterprise across all institutional boundaries. Key aspects of this opportunity include: • Support for three types of Cancer Centers: Comprehensive Cancer Centers, Clinical Cancer Centers, and Basic Cancer Centers • Emphasis on interdisciplinary research, including basic laboratory, clinical, and prevention, control, and population-based research • Requirement for applicant institutions to have a funding base of at least $10,000,000 in annual direct costs of NIH funding that is cancer-focused • Eligibility is limited to domestic (U.S.) institutions • Foreign components, as defined in the NIH Grants Policy Statement, are not allowed